Clinical Trials Browser

Carcinoma, Hepatocellular × contrast agent BR1 × Clear all

NCT04569799 2023-11-02

TACE

Phase 4 Completed

26 enrolled 10 charts

Gastrointestinal

Carcinoma, Hepatocellular

NCT04006275 2019-09-19

Comparing SonoVue With Sonazoid Using CEUS-LIRADS in HCC

Phase 3 Unknown

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular